There are 2789 resources available
1647TiP - Antiandrogen therapy and TMPRSS2 status: How prostate cancer patients are protected from COVID-19 pandemic
Presenter: Melanie Claps
Session: ePoster Display
1648P - Phased avelumab combined with chemotherapy as first-line treatment in extensive stage small cell lung cancer (PAVE): A phase II Hellenic Cooperative Oncology Group study
Presenter: Helena Linardou
Session: ePoster Display
1650P - Adoption and early clinical outcomes of atezolizumab (atezo) + carboplatin and etoposide (CE) in patients with extensive-stage small cell lung cancer (ES-SCLC) in the real-world (RW) setting
Presenter: David Chun Cheong Tsui
Session: ePoster Display
1651P - Phase I study of ramucirumab in combination with irinotecan plus cisplatin in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)
Presenter: Toshiaki Takahashi
Session: ePoster Display
1652P - Safety of simultaneously performed radiotherapy in patients with small cell lung cancer undergoing atezolizumab treatment
Presenter: Julia Galuba
Session: ePoster Display
1596P - SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis
Presenter: Anna Pous
Session: ePoster Display
1597P - Vaccination against SARS-CoV-2 infection in patients with solid tumors: Experience from Institute for Oncology and Radiology of Serbia (IORS)
Presenter: Ognjen Djurmez
Session: ePoster Display
1598P - Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study
Presenter: Maria João de Sousa
Session: ePoster Display
1599P - Vaccination in the COVID-19 era: Attitudes amongst oncology patients
Presenter: Sinead Horan
Session: ePoster Display